Long-Term Technology Forecast: AI in Remote Patient Monitoring Set to Reach $61.4B by 2040

The landscape of continuous care is reaching an inflection point. Remote patient monitoring (RPM) is rapidly transitioning from retrospective, reactive biometric tracking to proactive, AI-driven clinical intelligence.

According to a global market evaluation published by ResearchAndMarkets via GlobeNewswire, the global AI in Remote Patient Monitoring market is projected to surge from $3.35 billion in 2026 to $61.40 billion by 2040, representing an accelerated 23.1% compound annual growth rate (CAGR).

This massive multi-decade expansion highlights a structural shift across healthcare systems: continuous physiological data alone is no longer enough; the value lies in transforming high-frequency data streams into early, actionable clinical foresight.

What is Driving the 23.1% CAGR?

The forecast identifies critical clinical and technological drivers accelerating adoption across health systems and ambulatory practices:

• Edge Computing on Cellular Biosensors: Cellular-connected devices are evolving beyond passive data relays. Integrating edge processing directly with automated ingestion allows clinical teams to capture high-fidelity readings seamlessly—eliminating patient-side pairing barriers while enabling immediate data hygiene and signal validation.
• Predictive Risk Stratification & Automated Triage: Leveraging natural language processing (NLP) and predictive machine learning models, modern platforms can automatically triage population data, identify subtle micro-trends, and detect acute physiological deterioration days before an adverse clinical event occurs.
• Closing the Loop in High-Volume Chronic Disease: The highest-volume clinical applications remain concentrated in cardiovascular disease, hypertension, and diabetes. In these cohorts, predictive algorithms empower care teams to optimize medication titration dynamically, improve therapeutic adherence, and prevent avoidable emergency department visits and readmissions.

The HealthIQ & Eirion.ai Advantage

Capturing the real-world value of this $61B market requires bridging advanced machine learning directly with day-to-day clinical practice:

• Turnkey Clinical Delivery: HealthIQ provides the foundational operational framework—delivering friction-free cellular biosensors, clinical monitoring protocols, and integrated care workflows (RPM, CCM, and APCM) directly to independent practices and health systems.
• Predictive Intelligence at Scale: Eirion.ai delivers the predictive engine—applying specialized AI architectures and small language models across multi-modal inputs (RPM biometrics, longitudinal EHR records, and diagnostic lab data) to forecast adverse episodes before symptoms escalate.

Together, the synergy between robust clinical workflows and predictive AI turns passive biometric tracking into a powerful engine for value-based care, improved patient outcomes, and sustainable practice economics.

Reference: ResearchAndMarkets / GlobeNewswire: "AI in Remote Patient Monitoring Market Size and Forecast to 2040: Predictive Care Drives 23.1% CAGR to $61.40 Billion".